Page last updated: 2024-12-11
turanose
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
turanose : A glycosylfructose isolated from Daphnia magna. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5460935 |
| CHEBI ID | 32528 |
| SCHEMBL ID | 37172 |
| MeSH ID | M0093936 |
Synonyms (30)
| Synonym |
|---|
| alpha-d-glucopyranosyl-(1->3)-d-fructose |
| CHEBI:32528 |
| alpha-d-glcp-(1->3)-d-fru |
| 3-o-alpha-d-glucopyranosyl-d-fructose |
| turanose |
| 6DC826C6-9BDF-4B8B-AB8B-1E54ECA76A55 |
| alpha-d-glucopyranose-(1->3)-beta-d-fructose |
| beta-turanose |
| OTU , |
| C19636 |
| turanose (van) |
| unii-6d600ary3r |
| 6d600ary3r , |
| d-fructose, 3-o-alpha-d-glucopyranosyl- |
| nsc 1222 |
| einecs 208-918-5 |
| d-(+)-turanose (van) |
| S9448 |
| 3-(.alpha.-d-glucosido)-d-fructose |
| turanose [mi] |
| turanose, d- |
| SCHEMBL37172 |
| (3s,4r,5r)-1,4,5,6-tetrahydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexan-2-one |
| 3-o-hexopyranosylhex-2-ulose |
| 3-o-a-d-glucopyranosyl-d-fructose |
| (3s,4r,5r)-1,4,5,6-tetrahydroxy-3-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexan-2-one |
| 3-o-alpha-d-glucosyl-d-fructose; 3-o-d-glucosyl-d-fructose; 3-o-glucosyl-d-fructose |
| HY-113334 |
| CS-0059630 |
| DTXSID90876998 |
Research Excerpts
Overview
Turanose is a sucrose isomer naturally existing in honey. It is a promising functional sweetener due to its low glycemic response.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Turanose is a natural isomer of sucrose. " | ( Characterization of a novel amylosucrase gene from the metagenome of a thermal aquatic habitat, and its use in turanose production from sucrose biomass. Agarwal, N; Narnoliya, LK; Singh, SP, 2019) | 2.17 |
| "Turanose is a sucrose isomer naturally existing in honey and a promising functional sweetener due to its low glycemic response. " | ( Enzymatic Process for High-Yield Turanose Production and Its Potential Property as an Adipogenesis Regulator. Kang, HK; Kim, Y; Lee, BH; Lee, HG; Lim, E; Lim, JY; Park, CS; Park, MO; Yoo, SH, 2016) | 2.16 |
Treatment
Turanose treatments at concentrations representing 50%, 75%, and 100% of total glucose concentration in cell media significantly reduced lipid accumulation. Turanose-treated seedlings are characterized by a very short primary root and a short hypocotyl showing the production of adventitious roots.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Turanose treatments at concentrations representing 50%, 75%, and 100% of total glucose concentration in cell media significantly reduced lipid accumulation by 18%, 35%, and 72%, respectively, as compared to controls." | ( Enzymatic Process for High-Yield Turanose Production and Its Potential Property as an Adipogenesis Regulator. Kang, HK; Kim, Y; Lee, BH; Lee, HG; Lim, E; Lim, JY; Park, CS; Park, MO; Yoo, SH, 2016) | 1.44 |
| "Turanose-treated seedlings are characterized by a very short primary root and a short hypocotyl showing the production of adventitious roots." | ( A turanose-insensitive mutant suggests a role for WOX5 in auxin homeostasis in Arabidopsis thaliana. Alpi, A; Gonzali, S; Loreti, E; Novi, G; Paolicchi, F; Perata, P; Poggi, A, 2005) | 1.77 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Roles (1)
| Role | Description |
|---|---|
| Daphnia magna metabolite | A Daphnia metabolite produced by the species Daphnia magna. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Drug Classes (1)
| Class | Description |
|---|---|
| glycosylfructose | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Research
Studies (31)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 7 (22.58) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 38.86
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (38.86) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (3.03%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 32 (96.97%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||